Yang Jing, Liu Mengxiao, Fang Xidong, Zhang Huiyun, Ren Qian, Zheng Ya, Wang Yuping, Zhou Yongning
The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
Front Oncol. 2022 Dec 23;12:1081997. doi: 10.3389/fonc.2022.1081997. eCollection 2022.
The metastasis of malignant tumors determines patient prognosis. This is the main reason for the poor prognosis of patients with cancer and the most challenging aspect of treating malignant tumors. Therefore, it is important to identify early tumor markers and molecules that can predict patient prognosis. However, there are currently no molecular markers with good clinical accuracy and specificity. Many non-coding RNA (ncRNAs)have been identified, which can regulate the process of tumor development at multiple levels. Interestingly, some ncRNAs are translated to produce functional peptides. Exosomes act as signal carriers, are encapsulated in nucleic acids and proteins, and play a messenger role in cell-to-cell communication. Recent studies have identified exosome peptides with potential diagnostic roles. This review aims to provide a theoretical basis for ncRNA-encoded peptides or proteins transported by exosomes and ultimately to provide ideas for further development of new diagnostic and prognostic cancer markers.
恶性肿瘤的转移决定患者预后。这是癌症患者预后不良的主要原因,也是治疗恶性肿瘤最具挑战性的方面。因此,识别能够预测患者预后的早期肿瘤标志物和分子很重要。然而,目前尚无具有良好临床准确性和特异性的分子标志物。许多非编码RNA(ncRNA)已被鉴定出来,它们可在多个水平上调节肿瘤发展过程。有趣的是,一些ncRNA可被翻译产生功能性肽。外泌体作为信号载体,包裹着核酸和蛋白质,在细胞间通讯中起信使作用。最近的研究已鉴定出具有潜在诊断作用的外泌体肽。本综述旨在为外泌体转运的ncRNA编码肽或蛋白质提供理论基础,并最终为进一步开发新的癌症诊断和预后标志物提供思路。